Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol
- PMID: 18073275
- DOI: 10.1189/jlb.0907618
Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol
Abstract
We have previously reported that Delta-9-tetrahydrocannabinol (Delta(9)-THC)-treated mice challenged with influenza virus A/PR/8/34 (PR8) developed increased viral hemagglutinin 1 (H1) mRNA levels and decreased monocyte and lymphocyte recruitment to the pulmonary airways when compared with mice challenged with PR8 alone. The objective of the present study was to examine the role of cannabinoid (CB(1)/CB(2)) receptors in mediating the effects of Delta(9)-THC on immune and epithelial cell responses to PR8. In the current study, Delta(9)-THC-treated CB(1)/CB(2) receptor null (CB(1)-/-/CB(2)-/-) and wild-type mice infected with PR8 had marked increases in viral H1 mRNA when compared with CB(1)-/-/CB(2)-/- and wild-type mice challenged with PR8 alone. However, the magnitude of the H1 mRNA levels was greatly reduced in CB(1)-/-/CB(2)-/- mice as compared with wild-type mice. In addition, Delta(9)-THC-treated CB(1)-/-/CB(2)-/- mice infected with PR8 had increased CD4+ T cells and IFN-gamma in bronchoalveolar lavage fluid with greater pulmonary inflammation when compared with Delta(9)-THC-treated wild-type mice infected with PR8. Delta(9)-THC treatment of CB(1)-/-/CB(2)-/- mice in the presence or absence of PR8 challenge also developed greater amounts of mucous cell metaplasia in the affected bronchiolar epithelium. Collectively, the immune and airway epithelial cell responses to PR8 challenge in Delta(9)-THC-treated CB(1)-/-/CB(2)-/- and wild-type mice indicated the involvement of CB(1)/CB(2) receptor-dependent and -independent mechanisms.
Similar articles
-
Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice.J Pharmacol Exp Ther. 2007 Nov;323(2):675-83. doi: 10.1124/jpet.107.124719. Epub 2007 Aug 28. J Pharmacol Exp Ther. 2007. PMID: 17726158
-
Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.Eur J Pharmacol. 2006 Feb 17;532(1-2):170-7. doi: 10.1016/j.ejphar.2005.12.040. Epub 2006 Jan 27. Eur J Pharmacol. 2006. PMID: 16443217
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.Immunobiology. 2011 Apr;216(4):466-76. doi: 10.1016/j.imbio.2010.09.004. Epub 2010 Sep 18. Immunobiology. 2011. PMID: 21056512
-
The role of the endocannabinoid system in atherosclerosis.J Neuroendocrinol. 2008 May;20 Suppl 1:53-7. doi: 10.1111/j.1365-2826.2008.01685.x. J Neuroendocrinol. 2008. PMID: 18426500 Review.
-
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction.Trends Pharmacol Sci. 2012 Jun;33(6):331-40. doi: 10.1016/j.tips.2012.03.002. Epub 2012 Apr 13. Trends Pharmacol Sci. 2012. PMID: 22503477 Review.
Cited by
-
Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.Toxicol Sci. 2015 Jun;145(2):214-32. doi: 10.1093/toxsci/kfv060. Toxicol Sci. 2015. PMID: 26008184 Free PMC article. Review.
-
The CB2 receptor and its role as a regulator of inflammation.Cell Mol Life Sci. 2016 Dec;73(23):4449-4470. doi: 10.1007/s00018-016-2300-4. Epub 2016 Jul 11. Cell Mol Life Sci. 2016. PMID: 27402121 Free PMC article. Review.
-
Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.Arch Virol. 2021 Nov;166(11):3117-3126. doi: 10.1007/s00705-021-05223-7. Epub 2021 Sep 13. Arch Virol. 2021. PMID: 34514519 Free PMC article.
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.Arthritis Res Ther. 2015 Sep 6;17(1):226. doi: 10.1186/s13075-015-0743-x. Arthritis Res Ther. 2015. PMID: 26343051 Free PMC article. Review.
-
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.Toxicol Sci. 2013 Feb;131(2):419-33. doi: 10.1093/toxsci/kfs315. Epub 2012 Nov 14. Toxicol Sci. 2013. PMID: 23152191 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials